Cost-effectiveness of integrating buprenorphine-naloxone treatment for opioid use disorder into clinical care for persons with HIV/hepatitis C co-infection who inject opioids

BACKGROUND: Untreated opioid use disorder (OUD) affects the care of HIV/HCV co-infected people who inject opioids. Despite active injection opioid use, there is evidence of increasing engagement in HIV care and adherence to HIV medications among HIV/HCV co-infected persons. However, less than one-ha...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Drug Policy
Main Authors: Barocas, Joshua A., Morgan, Jake R., Fiellin, David A., Schackman, Bruce R., Yazdi, Golnaz Eftekhari, Stein, Michael D., Freedberg, Kenneth A., Linas, Benjamin P.
Formato: Artigo
Idioma:Inglês
Publicado em: 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6717527/
https://ncbi.nlm.nih.gov/pubmed/31085063
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.drugpo.2019.05.010
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados